Skip to main content
Clinical Trials/NL-OMON33969
NL-OMON33969Not yet recruitingNot Applicable

A new diagnostic development in MRI screening for breast cancer - CSI in breast cancer

niversitair Medisch Centrum Groningen0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • solid breast lesion >= 1cm
  • BIRADS classification 3 or 4 on the mammogram.
  • Patients are >= 18 years

Exclusion Criteria

  • history of breast cancer
  • breast hematoma
  • claustrophobia
  • non-MR compatible implants
  • disorder of kidney function

Investigators

Similar Trials

A new diagnostic development in MRI... | Clinical Trial